Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea

Summary

This is a 12-week, multicenter, double-blind, randomized, two-arm, vehicle controlled study. Subjects will be randomized 1:1 to BPX-04 minocycline topical gel 1% or vehicle. This study will include approximately 176 randomized subjects with inflammatory lesions of papulopustular rosacea on the face, defined by an IGA score of 3 (moderate) or 4 (severe) at Baseline. Subjects will be healthy male or female subjects aged 18 years or older. There will be up to 20 study sites in the USA.

Timeline

Start

2018-09-18

Primary completion

2019-05-17

Completion

2019-08-17

Drugs

Indications